Should You Pick CL Stock At $87?
CL stock, with 12% returns since the beginning of 2024, has underperformed the S&P 500 index, up 27%. The strengthening of ...
Major brands Nestle, Tyson, Shell, and Colgate added to X lawsuit alleging multi-billion-dollar plot to withhold ad revenue
X added seven companies to its lawsuit Saturday, alleging they partook in a World Federation of Advertisers-coordinated (WFA) ...
Colgate-Palmolive price target lowered to $105 from $110 at Raymond James
Raymond James lowered the firm’s price target on Colgate-Palmolive (CL) to $105 from $110 and keeps an Outperform rating on the shares. The ...
Colgate-Palmolive EPS Up, Revenue Lags
Colgate-Palmolive reported stable earnings for Q4 2024, beating EPS estimates but just missing revenue expectations.
Colgate looking to reduce the impact of possible tariffs on toothpaste made in Mexico
Colgate Palmolive is looking at ways to reduce the impact of possible tariffs on its toothpastes, which the company ...
Colgate-Palmolive price target lowered to $104 from $111 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Colgate-Palmolive (CL) to $104 from $111 and keeps an Overweight rating on the shares. The ...
Musk adds Shell, Nestlé, Lego to X advertiser ‘boycott’ lawsuit
Elon Musk’s X is adding several more companies to its lawsuit accusing firms of conspiring in an advertising “boycott” on the ...
Elon Musk's X sues Lego, Shell, more companies over advertising 'boycott' from platform
Elon Musk's X is suing more companies, alleging they joined a group of advertisers illegally conspiring to boycott the social ...
No, Elon: It Isn't Illegal To Boycott X
This, in turn, made X "a less effective competitor to other social media platforms in the sale of digital advertising and in ...
Colgate CEO points to urban warfare via deep discounts
Colgate-Palmolive CEO Noel Wallace highlighted intense discounting wars among consumer goods companies in India due to ...
Colgate-Palmolive's SWOT analysis: stock faces headwinds amid strong brand portfolio
Colgate-Palmolive (NYSE:CL), a global leader in consumer products with a "GOOD" InvestingPro Financial Health score of 2.73, finds itself at a crossroads as it navigates a complex market environment.